Synthetic Biology: The Next Biotech Revolution Is Brewing

Main Category: Pharma Industry / Biotech Industry
Also Included In: Conferences;  Biology / Biochemistry;  Water - Air Quality / Agriculture
Article Date: 13 Mar 2009 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Early applications of synthetic biology may be adequately addressed by the existing regulatory framework for biotechnology, but further advances in this emerging field are likely to create much greater challenges for the U.S. government, according to a new report authored by Michael Rodemeyer of the University of Virginia. Synthetic biology promises significant advances in areas such as biofuels, specialty chemicals, and agriculture and drug products.

In New Life, Old Bottles: Regulating First-Generation Products of Synthetic Biology, Rodemeyer examines the benefits and drawbacks of using the existing U.S. regulatory framework for biotechnology to cover the new products and processes enabled by synthetic biology. He finds that the similarities between biotechnology and synthetic biology are abundant enough for the current biotech oversight system to provide a good starting point, but it is not a perfect match.

According to Rodemeyer initial synthetic biology products will be relatively simple modifications on existing technology, but as the technology develops, regulatory agencies such as the Environmental Protection Agency and Food and Drug Administration will face challenges in assessing potential risks and controls. Laws like the Toxic Substances Control Act (TSCA) and Federal Food, Drug, and Cosmetic Act simply were not designed to handle 21st century advances.

You must register to attend. No RSVP is required to view the Webcast.

*** Webcast LIVE at http://www.nanotechproject.org/rodemeyer ***

What: Synthetic Biology: The Next Biotech Revolution Is Brewing

When: Wednesday, March 25, 2009, 12:30 - 1:30 PM (Light lunch available at 12 noon.)

Who: Michael Rodemeyer, adjunct instructor, University of Virginia David Rejeski, Director, Foresight & Governance Project, Moderator

Where: Woodrow Wilson International Center for Scholars, 5th Floor Conference Room in the Ronald Reagan Building at 1300 Pennsylvania Avenue, NW, Washington, DC. For directions see: http://www.wilsoncenter.org/directions

Notes:

New Life, Old Bottles was made possible with a grant from the European Commission to support pilot projects on "Transatlantic Methods for Handling Global Challenges." It is based on independent research and does not represent the views of the European Commission or the Woodrow Wilson International Center for Scholars. For more information, see: http://www.lse.ac.uk/nanoregulation.

Source: Colin Finan
Project on Emerging Nanotechnologies

Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Colin Finan. "Synthetic Biology: The Next Biotech Revolution Is Brewing." Medical News Today. MediLexicon, Intl., 13 Mar. 2009. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/142157.php>

APA
Colin Finan. (2009, March 13). "Synthetic Biology: The Next Biotech Revolution Is Brewing." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/142157.php.

Please note: If no author information is provided, the source is cited instead.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »